Efficacy of Alogliptin/Metformin Fixed-Dose Combination Tablets and Vildagliptin/Metformin Fixed-Dose Combination Tablets on Glycemic Control in Real-World Clinical Practice for the Patients with Type 2 Diabetes: A Multicenter, Open-Label, Randomized, Parallel Group, Comparative Trial
Metabolic Syndrome and Related Disorders · 2024
DOI: 10.1089/met.2024.0127 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Metabolic Syndrome and Related Disorders, 2024. Verfasst von Tomoe Abe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Metformin, Vildagliptin, Uracil. Die Arbeit nennt 39 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan.
- Sapporo Diabetes and Thyroid Clinic, Sapporo, Japan.
- Department of Diabetology and Endocrinology, Kanazawa Medical University, Uchinada, Japan.
- Caress Sapporo Hokko Memorial Clinic, Sapporo, Japan.
- Keiyukai Yoshida Hospital, Asahikawa, Japan.
- Department of Social and Environmental Medicine, Kanazawa Medical University, Uchinada, Japan.
ORCID-Profile: Yasutaka Takeda
Zitieren
APA
Abe, T., Takeda, Y., Sakuma, I., Okada, M., Kurigaki, A., Bessho, R., Sato, M., Kitsunai, H., Takiyama, Y., & Sakurai, M. (2024). Efficacy of Alogliptin/Metformin Fixed-Dose Combination Tablets and Vildagliptin/Metformin Fixed-Dose Combination Tablets on Glycemic Control in Real-World Clinical Practice for the Patients with Type 2 Diabetes: A Multicenter, Open-Label, Randomized, Parallel Group, Comparative Trial. Metabolic Syndrome and Related Disorders. https://doi.org/10.1089/met.2024.0127
Vancouver
Abe T, Takeda Y, Sakuma I, Okada M, Kurigaki A, Bessho R, et al. Efficacy of Alogliptin/Metformin Fixed-Dose Combination Tablets and Vildagliptin/Metformin Fixed-Dose Combination Tablets on Glycemic Control in Real-World Clinical Practice for the Patients with Type 2 Diabetes: A Multicenter, Open-Label, Randomized, Parallel Group, Comparative Trial. Metabolic Syndrome and Related Disorders. 2024. doi:10.1089/met.2024.0127
BibTeX
@article{Abe2024,
author = {Abe, Tomoe and Takeda, Yasutaka and Sakuma, Ichiro and Okada, Mizuho and Kurigaki, Ayaka and Bessho, Ryoichi and Sato, Mao and Kitsunai, Hiroya and Takiyama, Yumi and Sakurai, Masaru},
title = {Efficacy of Alogliptin/Metformin Fixed-Dose Combination Tablets and Vildagliptin/Metformin Fixed-Dose Combination Tablets on Glycemic Control in Real-World Clinical Practice for the Patients with Type 2 Diabetes: A Multicenter, Open-Label, Randomized, Parallel Group, Comparative Trial},
journal = {Metabolic Syndrome and Related Disorders},
year = {2024},
doi = {10.1089/met.2024.0127}
}
EUVIMED